231 related articles for article (PubMed ID: 21778099)
1. Inverse zonation of hepatocyte transduction with AAV vectors between mice and non-human primates.
Bell P; Wang L; Gao G; Haskins ME; Tarantal AF; McCarter RJ; Zhu Y; Yu H; Wilson JM
Mol Genet Metab; 2011 Nov; 104(3):395-403. PubMed ID: 21778099
[TBL] [Abstract][Full Text] [Related]
2. Enhancing Transgene Expression from Recombinant AAV8 Vectors in Different Tissues Using Woodchuck Hepatitis Virus Post-Transcriptional Regulatory Element.
Wang L; Wang Z; Zhang F; Zhu R; Bi J; Wu J; Zhang H; Wu H; Kong W; Yu B; Yu X
Int J Med Sci; 2016; 13(4):286-91. PubMed ID: 27076785
[TBL] [Abstract][Full Text] [Related]
3. The pleiotropic effects of natural AAV infections on liver-directed gene transfer in macaques.
Wang L; Calcedo R; Wang H; Bell P; Grant R; Vandenberghe LH; Sanmiguel J; Morizono H; Batshaw ML; Wilson JM
Mol Ther; 2010 Jan; 18(1):126-34. PubMed ID: 19888196
[TBL] [Abstract][Full Text] [Related]
4. AAV8-mediated hepatic gene transfer in infant rhesus monkeys (Macaca mulatta).
Wang L; Bell P; Lin J; Calcedo R; Tarantal AF; Wilson JM
Mol Ther; 2011 Nov; 19(11):2012-20. PubMed ID: 21811248
[TBL] [Abstract][Full Text] [Related]
5. Optimized adeno-associated virus (AAV)-protein phosphatase-5 helper viruses for efficient liver transduction by single-stranded AAV vectors: therapeutic expression of factor IX at reduced vector doses.
Jayandharan GR; Zhong L; Sack BK; Rivers AE; Li M; Li B; Herzog RW; Srivastava A
Hum Gene Ther; 2010 Mar; 21(3):271-83. PubMed ID: 19788390
[TBL] [Abstract][Full Text] [Related]
6. Adeno-associated virus-mediated gene transfer to nonhuman primate liver can elicit destructive transgene-specific T cell responses.
Gao G; Wang Q; Calcedo R; Mays L; Bell P; Wang L; Vandenberghe LH; Grant R; Sanmiguel J; Furth EE; Wilson JM
Hum Gene Ther; 2009 Sep; 20(9):930-42. PubMed ID: 19441963
[TBL] [Abstract][Full Text] [Related]
7. Targeting transgene to the heart and liver with AAV9 by different promoters.
Chen BD; He CH; Chen XC; Pan S; Liu F; Ma X; Li XM; Gai MT; Tao J; Ma YT; Yang YN; Gao XM
Clin Exp Pharmacol Physiol; 2015 Oct; 42(10):1108-17. PubMed ID: 26173818
[TBL] [Abstract][Full Text] [Related]
8. AAV-mediated liver-directed gene therapy.
Sands MS
Methods Mol Biol; 2011; 807():141-57. PubMed ID: 22034029
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of adeno-associated viral vectors for liver-directed gene transfer in dogs.
Bell P; Gao G; Haskins ME; Wang L; Sleeper M; Wang H; Calcedo R; Vandenberghe LH; Chen SJ; Weisse C; Withnall E; Wilson JM
Hum Gene Ther; 2011 Aug; 22(8):985-97. PubMed ID: 21204705
[TBL] [Abstract][Full Text] [Related]
10. Preexisting immunity and low expression in primates highlight translational challenges for liver-directed AAV8-mediated gene therapy.
Hurlbut GD; Ziegler RJ; Nietupski JB; Foley JW; Woodworth LA; Meyers E; Bercury SD; Pande NN; Souza DW; Bree MP; Lukason MJ; Marshall J; Cheng SH; Scheule RK
Mol Ther; 2010 Nov; 18(11):1983-94. PubMed ID: 20736932
[TBL] [Abstract][Full Text] [Related]
11. Intramuscular administration of AAV overcomes pre-existing neutralizing antibodies in rhesus macaques.
Greig JA; Calcedo R; Grant RL; Peng H; Medina-Jaszek CA; Ahonkhai O; Qin Q; Roy S; Tretiakova AP; Wilson JM
Vaccine; 2016 Dec; 34(50):6323-6329. PubMed ID: 27817961
[TBL] [Abstract][Full Text] [Related]
12. Autophagy determines efficiency of liver-directed gene therapy with adeno-associated viral vectors.
Hösel M; Huber A; Bohlen S; Lucifora J; Ronzitti G; Puzzo F; Boisgerault F; Hacker UT; Kwanten WJ; Klöting N; Blüher M; Gluschko A; Schramm M; Utermöhlen O; Bloch W; Mingozzi F; Krut O; Büning H
Hepatology; 2017 Jul; 66(1):252-265. PubMed ID: 28318036
[TBL] [Abstract][Full Text] [Related]
13. AAV8, 9, Rh10, Rh43 vector gene transfer in the rat brain: effects of serotype, promoter and purification method.
Klein RL; Dayton RD; Tatom JB; Henderson KM; Henning PP
Mol Ther; 2008 Jan; 16(1):89-96. PubMed ID: 17955025
[TBL] [Abstract][Full Text] [Related]
14. Selection and evaluation of clinically relevant AAV variants in a xenograft liver model.
Lisowski L; Dane AP; Chu K; Zhang Y; Cunningham SC; Wilson EM; Nygaard S; Grompe M; Alexander IE; Kay MA
Nature; 2014 Feb; 506(7488):382-6. PubMed ID: 24390344
[TBL] [Abstract][Full Text] [Related]
15. Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors.
Fraefel C; Jacoby DR; Lage C; Hilderbrand H; Chou JY; Alt FW; Breakefield XO; Majzoub JA
Mol Med; 1997 Dec; 3(12):813-25. PubMed ID: 9440115
[TBL] [Abstract][Full Text] [Related]
16. Biochemical correction of short-chain acyl-coenzyme A dehydrogenase deficiency after portal vein injection of rAAV8-SCAD.
Beattie SG; Goetzman E; Conlon T; Germain S; Walter G; Campbell-Thompson M; Matern D; Vockley J; Flotte TR
Hum Gene Ther; 2008 Jun; 19(6):579-88. PubMed ID: 18500942
[TBL] [Abstract][Full Text] [Related]
17. Effect of heart ischemia and administration route on biodistribution and transduction efficiency of AAV9 vectors.
García-Olloqui P; Rodriguez-Madoz JR; Di Scala M; Abizanda G; Vales Á; Olagüe C; Iglesias-García O; Larequi E; Aguado-Alvaro LP; Ruiz-Villalba A; Prosper F; Gonzalez-Aseguinolaza G; Pelacho B
J Tissue Eng Regen Med; 2020 Jan; 14(1):123-134. PubMed ID: 31677236
[TBL] [Abstract][Full Text] [Related]
18. Cellular selectivity of AAV serotypes for gene delivery in neurons and astrocytes by neonatal intracerebroventricular injection.
Hammond SL; Leek AN; Richman EH; Tjalkens RB
PLoS One; 2017; 12(12):e0188830. PubMed ID: 29244806
[TBL] [Abstract][Full Text] [Related]
19. Impact of age at administration, lysosomal storage, and transgene regulatory elements on AAV2/8-mediated rat liver transduction.
Cotugno G; Annunziata P; Barone MV; Karali M; Banfi S; Auricchio A
PLoS One; 2012; 7(3):e33286. PubMed ID: 22428010
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the relationship of AAV capsid domain swapping to liver transduction efficiency.
Shen X; Storm T; Kay MA
Mol Ther; 2007 Nov; 15(11):1955-62. PubMed ID: 17726459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
